Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis

Hepatology

Volumn 27, Issue 1, 1998, Pages 213-222

  Ghany, M G ^a   Ayola, B ^a   Villamil, F G ^a   Gish, R G ^a   Rojter, S ^a   Vierling, J M ^a   Lok, A S F ^a   Locarnini, S A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; INFECTION RISK; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; REINFECTION; VIRUS GENE;

EID: 0343406745     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270133     Document Type: Article

References (30)

1. 1 Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung J, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease. Hepatology 1991 ; 13: 619–626. MEDLINE
2. 2 O'Grady JG, Williams R. Liver transplantation for viral hepatitis. Br Med Bull 1990 ; 46: 481–491. MEDLINE
3. 3 Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993 ; 329: 1842–1847. MEDLINE
4. 4 Müller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, Tusch G, et al. Liver transplantation in HBs antigen (HBsAg) carriers: prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991 ; 13: 90–96. MEDLINE
5. 5 Bhatnagar PK, Papas E, Blum HE, Milich DR, Nitecki D, Karels MJ, Vyas GN. Immune response to synthetic peptide analogues of HBsAg for the a determinant. Proc Natl Acad Sci U S A 1982 ; 79: 4400–4404. MEDLINE
6. 6 Brown SE, Stanley C, Howard CR, Zuckerman AJ, Steward MW. Antibody responses to recombinant and plasma derived hepatitis B vaccines. Br Med J 1986 ; 292: 159–161.
7. 7 Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, et al. Vaccine‐induced escape mutant of hepatitis B virus. Lancet 1990 ; 336: 325–329. MEDLINE
8. 8 Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE, DeVera A, et al. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross‐protection. N Engl J Med 1982 ; 307: 1481–1486. MEDLINE
9. 9 McMahon G, Ehrlich P, Moustafa Z, McCarthy LA, Dottavio D, Tolpin MD, Nadler PI, et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody–treated liver transplant patients. Hepatology 1992 ; 15: 758–766.
10. 10 McNair ANB, Viaggi P, Smith HM, Tibbs CJ, Naoumov NV, Williams R. Hepatitis B envelope protein mutants. Lancet 1995 ; 346: 318–319. MEDLINE
11. 11 Hawkins AE, Gilson RJC, Gilbert N, Wreghitt TJ, Gray JJ, Ahlers‐de Boer I, Tedder RS, et al. Hepatitis B virus surface mutations associated with infection after liver transplantation. J Hepatol 1996 ; 24: 8–14. MEDLINE
12. 12 Carman WF, Trautwein C, van Deursen FJ, Colman K, Dornan E, McIntyre G, Waters J, et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996 ; 24: 489–493. MEDLINE
13. 13 Waters JA, Kennedy M, Voet P, Hauser P, Petre J, Carman W, Thomas HC. Loss of the common “a” determinant of hepatitis B surface antigen by a vaccine‐induced escape mutant. J Clin Invest 1992 ; 90: 2543–47. MEDLINE
14. 14 Villamil FG, Pan SH, Kuhns MC, Podesta LG, Sher L, Makowka L, Vierling JM. Efficacy and cost of long‐term intramuscular hepatitis B immunoglobulin (HBIG) in liver transplantation (LT) for hepatitis B [Abstract]. Hepatology 20: 129A.
15. 15 Jameson BA, Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci 1988 ; 4: 181–186. MEDLINE
16. 16 Norder H, Hammas B, Lee SD, Bile K, Courouce AM, Mushahwar IK, Magnius LO. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 1993 ; 74: 1341–1348. MEDLINE
17. 17 Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 1987 ; 61: 3030–3034. MEDLINE
18. 18 McCory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Disckson RC, Caldwell SH, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996 ; 61: 1358–1364. MEDLINE
19. 19 Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ. Independent emergence of a vaccine‐induced escape mutant of hepatitis B virus. J Hepatol 1991 ; 13 (Suppl 4: S105–107. MEDLINE
20. 20 Hino K, Okuda M, Hashimoto O, Ishiko H, Okazaki M, Fujii K, Hanada H, et al. Glycine‐to‐arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B antigen–positive carrier. Dig Dis Sci 1995 ; 40: 566–570. MEDLINE
21. 21 Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, Yamazaki M, et al. Gly 145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 1992 ; 184: 1152–1157. MEDLINE
22. 22 Bruce SA, Murray K. Mutations of some critical amino acid residues in the hepatitis B virus surface antigen. J Med Virol 1995 ; 46: 157–161. MEDLINE
23. 23 Neurath AR, Pride MW, Strick N, Thanavala YM. Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S(139–147). Peptide Res 1990 ; 3: 116–122.
24. 24 Borrego B, Novella IS, Giralt E, Andreau D, Domingo E. Distinct repertoire of antigenic variants of foot‐and‐mouth disease virus in the presence or absence of immune selection. J Virol 1993 ; 67: 6071–6079. MEDLINE
25. 25 Jilg W, Delhoune C, Deinhardt F, Roumeliotou‐Karayiannis AJ, Papaevangelou GJ, Mushahwar IK, Overby LR. Hepatitis B surface antigen (HBsAg) subtype‐specific antibodies in persons vaccinated against hepatitis B. J Med Virol 1984 ; 13: 171–178. MEDLINE
26. 26 Tai P, Banik D, Lin G, Pai S, Pai K, Lin MH, Yuoh G, et al. Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class‐I restricted T‐cell epitope of the surface antigen. J Virol 1997 ; 71: 4852–4856. MEDLINE
27. 27 Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas HC. A unique insertion in the S gene of surface antigen–negative hepatitis B virus Chinese carriers. Hepatology 1995 ; 21: 273–278. MEDLINE
28. 28 Lok ASF, Akarca US, Greene S. Mutations in the pre‐core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pregenome encapsidation signal. Proc Natl Acad Sci U S A 1994 ; 91: 4077–4081. MEDLINE
29. 29 Li JS, Tong SP, Wen YM, Vitvitski L, Zhang Q, Trepo C. Hepatitis B virus genotype A rarely circulates as an HBe‐minus mutant: possible contribution of a single nucleotide in the precore region. J Virol 1993 ; 67: 5402–5410. MEDLINE
30. 30 Laskus T, Rakela J, Persing DH. The stem‐loop structure of the cis‐encapsidation signal is highly conserved in naturally occurring hepatitis B virus variants. Virology 1994 ; 200: 809–812. MEDLINE